10Xing with Viking Therapeutics!
from Rebel's Edge with Jon & Pete Najarian
Join Jon and Pete Najarian on today's episode of Rebel's Edge as they discuss stocks including Viking Therapeutics coming to eat Eli Lilly and Novo Nordisk's lunch, Hims & Hers moving up hard, Zoom with a strong outlook, and Unity still failing to impress. Gain a deeper understanding of these stocks as Jon and Pete share their perspectives, potential growth prospects, and market predictions. They also talk about the NFL Combine and the Buccaneers. Stay on the cutting edge with Rebel's Edge.
Embed this episode
No transcript yet.
Similar podcasts
Frequently asked questions
How long is this episode of Rebel's Edge with Jon & Pete Najarian?
This episode is 30 minutes long.
When was this Rebel's Edge with Jon & Pete Najarian episode published?
This episode was published on February 27, 2024.
Can I download this Rebel's Edge with Jon & Pete Najarian episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.